Position in NVS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$937,028
+$134,633 QoQ
Shares Held
5,979
+13.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#642
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BENJAMIN EDWARDS INC holds $255,301,186 across 13 Drug Manufacturers - General names. NVS ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
327,322 | $82,367,307 | |
| 2 | JNJ |
Johnson & Johnson
|
160,633 | $40,795,962 | |
| 3 | LLY |
ELI LILLY & Co
|
29,114 | $34,920,207 | |
| 4 | MRK |
Merck & Co., Inc.
|
224,529 | $28,851,976 | |
| 5 | AMGN |
Amgen Inc
|
74,607 | $27,016,686 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
125,525 | $15,858,828 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
148,873 | $8,578,061 | |
| 8 | PFE |
Pfizer Inc
|
237,703 | $5,723,888 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $937,028 | 5,979 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $802,395 | 5,253 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $680,526 | 4,936 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $627,092 | 4,890 | Shares | Defined | 2025-10-23 | |
| 2025-06-30 | $520,343 | 4,300 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $456,399 | 4,094 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,593,949 | 36,933 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,232,374 | 45,491 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,547,587 | 23,930 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $2,295,983 | 23,736 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $2,327,762 | 23,054 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $2,761,220 | 27,108 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,399,034 | 23,774 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,844,048 | 20,044 | Shares | Defined | 2023-04-27 | |
| 2022-12-31 | $1,638,584 | 18,062 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $1,203,238 | 15,830 | Shares | Defined | 2022-10-28 | |
| 2022-06-30 | $1,414,947 | 16,739 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,508,773 | 17,194 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $1,017,538 | 11,633 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $41,462 | 507 | Shares | Defined | 2021-11-02 | |
| 2021-06-30 | $18,248 | 200 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $17,096 | 200 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $18,886 | 200 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $17,392 | 200 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $17,468 | 200 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $16,490 | 200 | Shares | Defined | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||